• Deutsch (DE-CH-AT)
  • English (United Kingdom)

NOTICE

with regard to the manufacturing license:
TICEBA
possesses the required authorization by the competent authority for the manufacturing of tissue as source material of human origin for the manufacturing of pharmaceuticals in accordance with § 20 b and § 20 c of the German Medicines Act: Authorization for the treatment or processing, preservation, storage of tissue or tissue preparations.

Your advantages from stem cell preservation


Preservation of our healthy adult stem cells as preventive measure on the highest level and in accordance with the latest scientific and technologic developments will be as self-evident as vaccination is today.

Prevention can hardly be any more intelligent!



Advantages of your stem cell preservation

Biological life insurance as preventive health care
Back-up copy of your young and healthy stem cells, as our genes are continuously exposed to environmental influences (viral infections, energetic radiation of earth and sun, environmental pollutants) that may cause considerable changes of the cells
Your spare parts store, as stem cells dispose of a renewal and repair function and replace defective cells
Manifold treatment possibilities, in which stem cells even today are of high significance and will play an even bigger role in the future


TICEBA offers security

TICEBA is a company founded and lead by physicians and therefore disposes of the necessary know-how with regard to the handling of stem cells.
TICEBA is the only company worldwide disposing of the exclusive license of the patent from Brigham and Women's Hospital, university hospital of the Harvard Medical School in Boston/USA, entitling them to determine and isolate the valuable ABCB5 positive stem cells.
At TICEBA, everything is in one hand: Thanks to our own cell biological laboratory and our own cryo-equipment, no risky cell transport is necessary and the patented process is exclusively carried out internally as well.
TICEBA takes a part in several research projects and thereby supports the research of the particularly important ABCB5 positive stem cells in order to be able to offer new areas of application and new chances in the future.

NEWS

TICEBA receives SME eligibility of EMA. continue »
TICEBA now on facebook. continue »
next event:
29. - 31. May 2012, ECOPRAM - European Congress on Preventive, Regenerative and Anti-Aging Medicine, Istanbul (Turkey). Topic: "Autologous pluripotent mesenchymal stem cells from the skin". Booth: 12. continue »

NEWSLETTER

INFORMATIONS

Request any information from us now.

COUNSELLING

"We are glad to counsel you in person", Dr. Christoph Ganss:
+49 (0)6221.718 33 0